This protocol describes a prospective cohort study. It addresses an important challenge in the prevention of colorectal cancer and duodenal cancer: how to safely and effectively remove large polyps.
Over recent years, a number of studies have been published that have highlighted factors associated with improved efficacy and safety of large polyp resection. Almost all of these studies originate from one large Australian cohort. It is unclear, whether the results are generalizable to other populations. It is important to understand if these findings can be duplicated, to further build on the gained knowledge. At the same time the technology of endoscopic resection is evolving. Established in 2012, the Large Polyp Study group aims to prospectively examine outcomes related to endoscopic large polyp removal. Enrollment of an ongoing randomized trial of 920 patients has just been completed and a second trial is planned. The primary aim of both trials is to understand whether a specific intervention will reduce the risk of adverse events. The added observational study will complement the trials in different ways: It will enroll patients who might not have been eligible for the trials and allow the application of other resection techniques. The observational study will therefore better represent the average patient who undergoes resection of a large polyp. Furthermore, it will add sample size to examine secondary outcomes with greater power. This is a continuation of NCT01936948 (Safety of Endoscopic Resection of Large Colorectal Polyps: A Randomized Trial) as a observational cohort. The continuation was approved by the institutional IRB as part of the initial RCT. At this point the investigators document the observational arm as its own study in this registry.
Study Type
OBSERVATIONAL
Enrollment
1,500
White River Junction VAMC
White River Junction, Vermont, United States
RECRUITINGIncidence of severe complications
Aggregate of all severe adverse events that occur at the time of the procedure or during and up to 14 days of follow-up. Severe adverse events include bleeding, perforation, postpolypectomy syndrome, and clinical events that require an admission to the hospital.
Time frame: Up to 14 days following the procedure.
Completeness of polyp resection
Complete polyp removal is defined as removal of all visible polyp tissue at the end of the EMR, as assessed by the endoscopist.
Time frame: During the procedure
Polyp recurrence
Presence of biopsy proven neoplastic polyp tissue at the EMR resection site at surveillance endoscopy following complete polyp resection.
Time frame: Up to 5 years (at next scheduled surveillance colonoscopy).
Severe bleeding complications
Severe bleeding is defined as the need for hospitalization, transfusion, a repeat endoscopy, surgery, or interventional radiology, up to 14 days following the procedure.
Time frame: Up to 14 days following the procedure.
Perforation
Defined as a complete hole, or full-thickness resection of the muscularis propria (Sydney Classification of Deep Mural Injury Type IV)
Time frame: Up to 14 days following the procedure.
Postpolypectomy syndrome
Defined as abdominal pain severe enough to warrant an ED visit or hospital admission and presence of leukocytosis and/or required treatment with antibiotics.
Time frame: Following the procedure up to 14 days.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Efficacy of submucosal injectate
Volume of solution per lesion size (mL/cm2), time of resection.
Time frame: During the procedure.
Intraprocedural bleeding
Immediate bleeding that requires endoscopic intervention to stop the bleeding (e.g. clip placement or snare tip soft coagulation or coagulation grasper).
Time frame: During the procedure
Need for colon resection
Patients who require surgery for polyp removal or as a result of complications related to the EMR or follow up procedures.
Time frame: Up to 3 years following the procedure.
Technical skill of the endoscopist
To perform video based assessment of endoscopic resection skills
Time frame: During the procedure
Cold snare of duodenal adenomas greater than 10 mm
Safety, efficacy, recurrence of neoplastic polyp at first surveillance endoscopy, serious adverse events
Time frame: Up to 3 years following baseline procedure
Cold snare of Paris IIa polyps greater than 20 mm
Safety, efficacy, recurrence, serious adverse events
Time frame: 1 year following baseline procedure